Sucroferric Oxyhydroxide

蔗糖氢氧化氧铁

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameSucroferric Oxyhydroxide
Drug Alias NameFERRIC OXYHYDROXIDE蔗糖羟基氧化铁多核羟基氧化铁（III）维福瑞VELPHORO +[12] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionIron Supplements
TargetsNot applicable
Therapy Area/IndicationsHyperphosphatemiaRenal Insufficiency, Chronic
Global Approved IndicationsHyperphosphatemia
Approved Indications in ChinaHyperphosphatemia
Original Approved Country/TerritoryUnited States
Original Approved Date2013/11/27
Country/TerritoryUnited StatesPolandRomania +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesVifor Fresenius Medical Care Renal Pharma France
China Registration ClassN/A

Develop Information

Active CompaniesVifor Fresenius Medical Care Renal Pharma LtdVifor Fresenius Medical Care Renal Pharma France
Inactive CompaniesVifor Sa
Active IndicationsHyperphosphatemia
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG